Migration of gastric cancer cells in response to lysophosphatidic acid is mediated by LPA receptor 2

Oncology Letters

Volumn 5, Issue 3, 2013, Pages 1048-1052

  Yang, Dezhi ^a   Yang, Wenhua ^a   Zhang, Qian ^a   Hu, Yan ^a   Bao, Liang ^a   Damirin, Alatangaole ^a  

^a INNER MONGOLIA UNIVERSITY   (China)

Author keywords

Cell migration; Gastric cancer; Gq 11; Lysophosphatidic acid receptor2 (LPAR2)

Indexed keywords

AG 1487; EPIDERMAL GROWTH FACTOR; G PROTEIN COUPLED RECEPTOR; KI 16425; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDIC ACID RECEPTOR; LYSOPHOSPHATIDIC ACID RECEPTOR 2; MESSENGER RNA; PERTUSSIS TOXIN; RECEPTOR BLOCKING AGENT; SMALL INTERFERING RNA; SYNAPTOPHYSIN; UNCLASSIFIED DRUG; YM 254890;

ARTICLE; CELL COUNT; CELL MIGRATION; CONTROLLED STUDY; GENE SILENCING; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; STOMACH CANCER; WESTERN BLOTTING;

EID: 84872738737     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1107     Document Type: Article

References (32)

1. Aoki J, Taira A, Takanezawa Y, et al: Serum lysophosphatidic acid is produced through diverse phospholipase pathways. J Biol Chem 277: 48737-48744, 2002.
2. Contos JJ, Ishii I and Chun J: Lysophosphatidic acid receptors. Mol Pharmacol 58: 1188-1196, 2000.
3. Moolenaar WH: Bioactive lysophospholipids and their G protein-coupled receptors. Exp Cell Res 253: 230-238, 1999.
4. Ye X, Ishii I, Kingsbury MA and Chun J: Lysophosphatidic acid as a novel cell survival/apoptotic factor. Biochim Biophys Acta 1585: 108-113, 2002.
5. Xu Y, Gaudette DC, Boynton JD, et al: Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients. Clin Cancer Res 1: 1223-1232, 1995.
6. Siess W, Zangl KJ, Essler M, et al: Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions. Proc Natl Acad Sci USA 96: 6931-6936, 1999.
7. 2+ influx in human platelets. J Biol Chem 275: 19159-19166, 2000.
8. Xu Y, Xiao YJ, Baudhuin LM and Schwartz BM: The role and clinical applications of bioactive lysolipids in ovarian cancer. J Soc Gynecol Investig 8: 1-13, 2001.
9. Li H, Ye X, Mahanivong C, Bian D, Chun J and Huang S: Signaling mechanisms responsible for lysophosphatidic acid-induced urokinase plasminogen activator expression in ovarian cancer cells. J Biol Chem 280: 10564-10571, 2005.
10. Smicun Y, Gil O, Devine K and Fishman DA: S1P and LPA have an attachment-dependent regulatory effect on invasion of epithelial ovarian cancer cells. Gynecol Oncol 107: 298-309, 2007.
11. Symowicz J, Adley BP, Woo MM, Auersperg N, Hudson LG and Stack MS: Cyclooxygenase-2 functions as a downstream mediator of lysophosphatidic acid to promote aggressive behavior in ovarian carcinoma cells. Cancer Res 65: 2234-2242, 2005.
12. Xu Y, Shen Z, Wiper DW, et al: Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers. JAMA 280: 719-723, 1998.
13. An S, Bleu T, Zheng Y and Goetzl EJ: Recombinant human Gprotein-coupled lysophosphatidic acid receptors mediate intracellular calcium mobilization. Mol Pharmacol 54: 881-888, 1998.
14. Bandoh K, Aoki J, Hosono H, et al: Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid. J Biol Chem 274: 27776-27785, 1999.
15. Hecht JH, Weiner JA, Post SR and Chun J: Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex. J Cell Biol 135: 1071-1083, 1996.
16. Im DS, Heise CE, Harding MA, et al: Molecular cloning and characterization of a lysophosphatidic acid receptor, Edg-7, expressed in prostate. Mol Pharmacol 57: 753-759, 2000.
17. Noguchi K, Ishii S and Shimizu T: Identification of p2y9/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family. J Biol Chem 278: 25600-25606, 2003.
18. Li W, Yu CP, Xia JT, et al: Sphingosine kinase 1 is associated with gastric cancer progression and poor survival of patients. Clin Cancer Res 15: 1393-1399, 2009.
19. Shida D, Kitayama J, Yamaguchi H, et al: Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1. Cancer Res 63: 1706-1711, 2003.
20. Yamashita H, Kitayama J, Shida D, et al: Differential expression of lysophosphatidic acid receptor-2 in intestinal and diffuse type gastric cancer. J Surg Oncol 93: 30-35, 2006.
21. Ohta H, Sato K, Murata N, et al: Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors. Mol Pharmacol 64: 994-1005, 2003.
22. Damirin A, Tomura H, Komachi M, et al: Role of lipoprotein-associated lysophospholipids in migratory activity of coronary artery smooth muscle cells. Am J Physiol Heart Circ Physiol 292: H2513-H2522, 2007.
23. Gibbs JB: Mechanism-based target identification and drug discovery in cancer research. Science 287: 1969-1973, 2000.
24. Choi JW, Herr DR, Noguchi K, et al: LPA receptors: subtypes and biological actions. Annu Rev Pharmacol Toxicol 50: 157-186, 2010.
25. Murray D, Horgan G, Macmathuna P and Doran P: NET1-mediated RhoA activation facilitates lysophosphatidic acid-induced cell migration and invasion in gastric cancer. Br J Cancer 99: 1322-1329, 2008.
26. Ramachandran S, Shida D, Nagahashi M, et al: Lysophosphatidic acid stimulates gastric cancer cell proliferation via ERK1-dependent upregulation of sphingosine kinase 1 transcription. FEBS Lett 584: 4077-4082, 2010.
27. Zhang R, Wang J, Ma S, Huang Z and Zhang G: Requirement of Osteopontin in the migration and protection against Taxol-induced apoptosis via the ATX-LPA axis in SGC7901 cells. BMC Cell Biol 12: 11, 2011.
28. Goetzl EJ, Dolezalova H, Kong Y, et al: Distinctive expression and functions of the type 4 endothelial differentiation gene-encoded G protein-coupled receptor for lysophosphatidic acid in ovarian cancer. Cancer Res 59: 5370-5375, 1999.
29. Shida D, Watanabe T, Aoki J, et al: Aberrant expression of lysophosphatidic acid (LPA) receptors in human colorectal cancer. Lab Invest 84: 1352-1362, 2004.
30. Hope JM, Wang FQ, Whyte JS, et al: LPA receptor 2 mediates LPA-induced endometrial cancer invasion. Gynecol Oncol 112: 215-223, 2009.
31. Xu J, Lai YJ, Lin WC and Lin FT: TRIP6 enhances lysophosphatidic acid-induced cell migration by interacting with the lysophosphatidic acid 2 receptor. J Biol Chem 279: 10459-10468, 2004.
32. Fang X, Yu S, Bast RC, et al: Mechanisms for lysophosphatidic acid-induced cytokine production in ovarian cancer cells. J Biol Chem 279: 9653-9661, 2004.